Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Jun 20, 2024

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Tectonic Therapeutic Inc	Timothy A. Springer	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	2,692,005	2,692,005	-		-	Common Stock
Tectonic Therapeutic Inc	Timothy A. Springer	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	1,551,116	1,551,116	-		-	Common Stock
Tectonic Therapeutic Inc	Stefan Vitorovic	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	1,000,900	1,000,900	-		-	Common Stock
Erasca Inc	Jonathan E. Lim	Director, Chairman & CEO, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	632,759	632,759	-		-	Stock Option (right to buy)
TeraWulf Inc Fundraise	Paul B. Prager	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	500,000	723,500	-		-	Common stock, $0.001 par value per share
TeraWulf Inc Fundraise	Paul B. Prager	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	500,000	500,000	-		-	Performance-Based Restricted Stock Units
TeraWulf Inc Fundraise	Nazar M. Khan	Director, Chief Operating Officer + CTO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	400,000	400,000	-		-	Performance-Based Restricted Stock Units
TeraWulf Inc Fundraise	Nazar M. Khan	Director, Chief Operating Officer + CTO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	400,000	13,801,084	-		-	Common stock, $0.001 par value per share
GSK PLC (ADR)	Emma N. Walmsley	Executive Director,Chief Executive Officer		20 Jun 2024	371,100	375,145 (0%)	0%		0	Ords 0.31p
Nuvation Bio Inc (Class A)	Xiangmin Cui	Director	Purchase of securities on an exchange or from another person at price $ 2.98 per share.	20 Jun 2024	336,874	2,175,236	-	3.0	1,003,885	Class A Common Stock
Tectonic Therapeutic Inc	Alise S. Reicin	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	289,600	289,600	-		-	Employee Stock Option (Right to Buy)
Erasca Inc	David M. Chacko	CFO and CBO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	278,812	278,812	-		-	Stock Option (right to buy)
TeraWulf Inc Fundraise	Paul B. Prager	Director, Chief Executive Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	20 Jun 2024	276,500	447,000	-		-	Common stock, $0.001 par value per share
Purple Innovation Inc	Robert T. DeMartini	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	241,157	241,157	-		-	Restricted Stock Units
Oracle Dividend	Edward Screven	Chief Corporate Architect		20 Jun 2024	235,918	2,862,682 (0%)	0%	40.5	9,547,601	Common Stock
Oracle Dividend	Edward Screven	Chief Corporate Architect		20 Jun 2024	235,918	464,082	-		-	Stock Option
TeraWulf Inc Fundraise	Nazar M. Khan	Director, Chief Operating Officer + CTO	Sale or transfer of securities back to the company at price $ 0.00 per share.	20 Jun 2024	221,200	13,579,884	-		-	Common stock, $0.001 par value per share
Oracle Dividend	Edward Screven	Chief Corporate Architect		20 Jun 2024	202,648	2,660,034 (0%)	0%	144.2	29,214,567	Common Stock
Insight Molecular Diagnostics Inc	Andrea James	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	200,000	200,000	-		-	Option to Purchase Common Stock
GlycoMimetics Inc	Edwin Rock	Chief Medical Officer		20 Jun 2024	190,000	565,403 (1%)	0%	0.3	48,108	Common Stock
Tectonic Therapeutic Inc	Alise S. Reicin	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	166,580	166,580	-		-	Common Stock
Erasca Inc	Ebun S. Garner	General Counsel & Corp. Sec.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	160,082	160,082	-		-	Stock Option (right to buy)
TeraWulf Inc Fundraise	Patrick A. Fleury	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	140,000	140,000	-		-	Performance-Based Restricted Stock Units
TeraWulf Inc Fundraise	Patrick A. Fleury	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	140,000	1,806,359	-		-	Common stock, $0.001 par value per share
TeraWulf Inc Fundraise	Kerri M. Langlais	Director, Chief Strategy Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	140,000	2,339,619	-		-	Common stock, $0.001 par value per share
TeraWulf Inc Fundraise	Kerri M. Langlais	Director, Chief Strategy Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	140,000	140,000	-		-	Performance-Based Restricted Stock Units
Erasca Inc	Shannon R. Morris	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	137,142	137,142	-		-	Stock Option (right to buy)
Tectonic Therapeutic Inc	Christian Cortis	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	126,368	126,368	-		-	Common Stock
Tectonic Therapeutic Inc	Alise S. Reicin	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	124,530	124,530	-		-	Common Stock
Robinhood Markets Inc (Class A)	Baiju Bhatt	Director		20 Jun 2024	121,226	121,226	-		-	Class A Common Stock
Robinhood Markets Inc (Class A)	Baiju Bhatt	Director		20 Jun 2024	121,226	58,430,564	-		-	Class B Common Stock
Robinhood Markets Inc (Class A)	Baiju Bhatt	Director	Sale of securities on an exchange or to another person at price $ 21.63 per share.	20 Jun 2024	121,226	0	-	21.6	2,622,712	Class A Common Stock
Tectonic Therapeutic Inc	Daniel Lochner	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	118,000	118,000	-		-	Employee Stock Option (Right to Buy)
SoundHound AI Inc (Class A)	Keyvan Mohajer	Director, CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 3.95 per share.	20 Jun 2024	116,504	953,333	-	3.9	459,853	Class A Common Stock
GlycoMimetics Inc	Edwin Rock	Chief Medical Officer		20 Jun 2024	115,000	680,403 (1%)	0%	0.3	30,717	Common Stock
Rithm Cap Corp	Michael Nierenberg	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.15 per share.	20 Jun 2024	106,546	1,159,571 (0%)	0%	11.2	1,187,988	Common Stock
Snowflake Inc (Class A)	Christopher W. Degnan	Chief Revenue Officer		20 Jun 2024	100,589	239,563	-		0	Class A Common Stock
Insight Molecular Diagnostics Inc	Andrea James	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	100,000	300,000	-		-	Restricted Stock Units
Tectonic Therapeutic Inc	Marc Schwabish	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	91,214	91,214	-		-	Employee Stock Option (Right to Buy)
Nuvation Bio Inc (Class A)	Xiangmin Cui	Director	Purchase of securities on an exchange or from another person at price $ 2.99 per share.	20 Jun 2024	87,715	1,762,951	-	3.0	262,268	Class A Common Stock
Ideal Power Inc	R. Daniel Brdar	Director, President and CEO		20 Jun 2024	85,000	175,026 (8%)	4%		0	Common Stock
Tectonic Therapeutic Inc	Marcella Kuhlman Ruddy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	81,700	81,700	-		-	Employee Stock Option (Right to Buy)
Sonim Tech Inc	James S. Cassano	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	78,947	310,027 (1%)	0%		0	Common Stock
Sonim Tech Inc	Michael C. Mulica	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	78,947	464,172 (2%)	0%		0	Common Stock
Sonim Tech Inc	Jeffrey Wang	Director, Ten Percent Owner		20 Jun 2024	78,947	310,027 (1%)	0%		0	Common Stock
Sonim Tech Inc	Jack Steenstra	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	78,947	310,027 (1%)	0%		0	Common Stock
TeraWulf Inc Fundraise	Kerri M. Langlais	Director, Chief Strategy Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	20 Jun 2024	77,420	2,262,199	-		-	Common stock, $0.001 par value per share
Tectonic Therapeutic Inc	Peter McNamara	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	77,000	77,000	-		-	Employee Stock Option (Right to Buy)
Nuvation Bio Inc (Class A)	Xiangmin Cui	Director	Purchase of securities on an exchange or from another person at price $ 3.00 per share.	20 Jun 2024	75,411	1,838,362	-	3	226,233	Class A Common Stock
SoundHound AI Inc (Class A)	Keyvan Mohajer	Director, CEO, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 4.04 per share.	20 Jun 2024	67,994	1,069,837	-	4.0	274,689	Class A Common Stock
NexPoint Diversified Real Estate Trust	Dustin Norris	See Remarks	Purchase of securities on an exchange or from another person at price $ 4.73 per share.	20 Jun 2024	63,430	104,057 (0%)	0%	4.7	300,024	Common Stock
Purple Innovation Inc	Eric S. Haynor	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	63,303	63,303	-		-	Restricted Stock Units
Tectonic Therapeutic Inc	Marc Schwabish	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	61,600	61,600	-		-	Employee Stock Option (Right to Buy)
Atlas Energy Soln Inc (Class A)	Gregory M. Shepard	Member of 10% Owner Group	Purchase of securities on an exchange or from another person at price $ 19.05 per share.	20 Jun 2024	60,393	7,383,018	-	19.1	1,150,487	Common Stock
Erasca Inc	Alexander W. Casdin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	60,000	60,000	-		-	Stock Option (right to buy)
Erasca Inc	Jean I. Liu	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	60,000	60,000	-		-	Stock Option (right to buy)
Erasca Inc	Julie Hambleton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	60,000	60,000	-		-	Stock Option (right to buy)
Erasca Inc	Pratik S. Multani	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	60,000	60,000	-		-	Stock Option (right to buy)
Erasca Inc	James A. Bristol	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	60,000	60,000	-		-	Stock Option (right to buy)
Erasca Inc	Michael D. Varney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	60,000	60,000	-		-	Stock Option (right to buy)
Erasca Inc	Valerie Harding Start	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	60,000	60,000	-		-	Stock Option (right to buy)
Life360 Inc	Lauren Antonoff	Chief Operating Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.25 per share.	20 Jun 2024	57,806	338,501	-	31.3	1,806,438	Common Stock
SoFi Tech Inc	Jeremy Rishel	Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 6.41 per share.	20 Jun 2024	56,273	453,464	-	6.4	360,710	Common Stock
Purple Innovation Inc	Keira M. Krausz	Chief Marketing Officer		20 Jun 2024	56,069	56,069	-		-	Restricted Stock Units
Tectonic Therapeutic Inc	Christian Cortis	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	56,061	56,061	-		-	Employee Stock Option (Right to Buy)
TeraWulf Inc Fundraise	Patrick A. Fleury	Chief Financial Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	20 Jun 2024	55,090	1,751,269	-		-	Common stock, $0.001 par value per share
AMMO Inc	Fred W. Wagenhals	Director, EXECUTIVE CHAIR	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	55,000	7,121,700	-		0	Common Stock
TeraWulf Inc Fundraise	Kenneth J. Deane	Chief Acct Officer + Treasurer		20 Jun 2024	54,000	391,245	-		-	Common stock, $0.001 par value per share
TeraWulf Inc Fundraise	Kenneth J. Deane	Chief Acct Officer + Treasurer		20 Jun 2024	54,000	54,000	-		-	Performance-Based Restricted Stock Units
Sonoma Pharma Inc	Amy M. Trombly	Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	53,586	153,586 (8%)	3%		-	Common Stock, $0.0001 par value
Sonoma Pharma Inc	Bruce Thornton	Executive Vice President		20 Jun 2024	53,586	154,411 (8%)	3%		-	Common Stock, $0.0001 par value
Sonoma Pharma Inc	Jerome J. Dvonch	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	53,586	84,595 (4%)	3%		-	Common Stock, $0.0001 par value
Purple Innovation Inc	Jeffrey Layne Hutchings	Chief Innovation Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	50,643	50,643	-		-	Restricted Stock Units
Sunrun Inc	Lynn Jurich	Director	Sale of securities on an exchange or to another person at price $ 12.11 per share.	20 Jun 2024	50,000	1,344,383 (1%)	0%	12.1	605,305	Common Stock
Roadzen Inc	Supurna VedBrat	Director	Other type of transaction at price $ 0.00 per share.	20 Jun 2024	50,000	50,000	-		-	Warrants
Snowflake Inc (Class A)	Christopher W. Degnan	Chief Revenue Officer		20 Jun 2024	50,000	139,563	-		0	Class A Common Stock
Snowflake Inc (Class A)	Christopher W. Degnan	Chief Revenue Officer		20 Jun 2024	50,000	189,563	-		0	Class A Common Stock
Alto Ingredients Inc	Douglas L. Kieta	Director		20 Jun 2024	49,166	315,828 (0%)	0%		0	Common Stock
Alset Inc	Fai Heng Chan	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 1.22 per share.	20 Jun 2024	47,536	5,720,631	-	1.2	57,994	Common Stock
Century Therapeutics Inc	Cynthia M. Butitta	Director		20 Jun 2024	44,000	44,000	-		-	Stock Option (right to buy)
Century Therapeutics Inc	Joseph Jimenez	Director		20 Jun 2024	44,000	44,000	-		-	Stock Option (right to buy)
Century Therapeutics Inc	Timothy P. Walbert	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	44,000	44,000	-		-	Stock Option (right to buy)
Century Therapeutics Inc	Daphne Quimi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	44,000	44,000	-		-	Stock Option (right to buy)
Century Therapeutics Inc	Kimberly L. Blackwell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	44,000	44,000	-		-	Stock Option (right to buy)
Century Therapeutics Inc	Carlo Rizzuto	Director		20 Jun 2024	44,000	44,000	-		-	Stock Option (right to buy)
Century Therapeutics Inc	Alessandro Riva	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	44,000	44,000	-		-	Stock Option (right to buy)
Tectonic Therapeutic Inc	Marcella Kuhlman Ruddy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	43,946	43,946	-		-	Employee Stock Option (Right to Buy)
ChargePoint Holdings Inc (Class A)	Henrik Gerdes	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 1.51 per share.	20 Jun 2024	43,596	438,004	-	1.5	65,612	Common Stock
AMMO Inc	Jared R. Smith	Director, CEO		20 Jun 2024	43,333	367,937	-		0	Common Stock
Atea Pharma Inc	Bruce Polsky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	41,200	41,200	-		-	Stock Option (Right to Buy)
Purple Innovation Inc	Jeffery Scott Kerby	Chief of Owned Retail	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	40,755	40,755	-		-	Restricted Stock Units
Ideal Power Inc	Timothy W. Burns	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	40,000	86,879 (4%)	1%		0	Common Stock
Assured Guaranty Ltd	Dominic J. Frederico	Director, President/CEO/Deputy Chairman	Sale of securities on an exchange or to another person at price $ 78.12 per share.	20 Jun 2024	40,000	1,410,824 (1%)	0%	78.1	3,124,800	Common Shares
ARS Pharma Inc	Brenton L. Saunders	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Peter A. Thompson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Phillip M. Schneider	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Laura Shawver	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Saqib Islam	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Pratik Shah	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Rajeev Dadoo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
ARS Pharma Inc	Michael Kelly	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	40,000	40,000	-		-	Stock Option (right to buy)
Aquestive Therapeutics Inc	Gregory B. Brown	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	38,000	38,000	-		-	Stock Option (Right to Purchase)
Aquestive Therapeutics Inc	Santo J. Costa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	38,000	38,000	-		-	Stock Option (Right to Purchase)
Aquestive Therapeutics Inc	Timothy E. Morris	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	38,000	38,000	-		-	Stock Option (right to purchase)
Aquestive Therapeutics Inc	Marco Taglietti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	38,000	38,000	-		-	Stock Option (Right to Purchase)
Aquestive Therapeutics Inc	Julie Krop	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	38,000	38,000	-		-	Stock Option (Right to Purchase)
Aquestive Therapeutics Inc	John S. Cochran	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	38,000	38,000	-		-	Stock Option (Right to Purchase)
Tectonic Therapeutic Inc	Peter McNamara	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	37,959	37,959	-		-	Employee Stock Option (Right to Buy)
XBiotech Inc	W. Thorpe Mckenzie	Director, Ten Percent Owner		20 Jun 2024	37,500	37,500	-		-	Director Stock Option
XBiotech Inc	Donald MacAdam	Director		20 Jun 2024	37,500	37,500	-		-	Director Stock Option
XBiotech Inc	Jan-Paul Waldin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	37,500	37,500	-		-	Director Stock Option
XBiotech Inc	Peter Libby	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	37,500	37,500	-		-	Director Stock Option
Yext Inc	Darryl Bond	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	37,500	346,686 (0%)	0%		-	Common Stock
Yext Inc	Darryl Bond	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	37,500	262,500	-		-	Restricted Stock Unit
Equity Residential - REIT	David J. Neithercut	Director, Chairman of the Board	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	37,337	37,337	-		-	Non-qualified Stock Option (Right to Buy)
Alto Ingredients Inc	Gilbert E. Nathan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	36,666	675,575 (1%)	0%		0	Common Stock
Alto Ingredients Inc	Dianne S. Nury	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	36,666	180,744 (0%)	0%		0	Common Stock
Alto Ingredients Inc	Maria G. Gray	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	36,666	118,958 (0%)	0%		0	Common Stock
Sonim Tech Inc	Michael C. Mulica	Director	Sale of securities on an exchange or to another person at price $ 0.69 per share.	20 Jun 2024	36,016	428,156 (2%)	0%	0.7	24,851	Common Stock
Sonim Tech Inc	Jeffrey Wang	Director, Ten Percent Owner		20 Jun 2024	36,016	274,011 (1%)	0%	0.7	24,851	Common Stock
Sonim Tech Inc	James S. Cassano	Director	Sale of securities on an exchange or to another person at price $ 0.69 per share.	20 Jun 2024	36,015	274,012 (1%)	0%	0.7	24,850	Common Stock
Galecto Inc	Carl S. Goldfischer	Director		20 Jun 2024	36,000	36,000	-		-	Stock Option (right to buy)
Sonim Tech Inc	Jack Steenstra	Director	Sale of securities on an exchange or to another person at price $ 0.69 per share.	20 Jun 2024	35,882	274,145 (1%)	0%	0.7	24,759	Common Stock
Pinterest Inc (Class A)	Julia Brau Donnelly	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.01 per share.	20 Jun 2024	35,192	393,102 (0%)	0%	44.0	1,548,800	Class A Common Stock
Yext Inc	Ho Shin	General Counsel	Sale of securities on an exchange or to another person at price $ 5.04 per share.	20 Jun 2024	35,000	125,207 (0%)	0%	5.0	176,446	Common Stock
Tectonic Therapeutic Inc	Alise S. Reicin	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	33,923	33,923	-		-	Employee Stock Option (Right to Buy)
MaxCyte Inc	Thomas M. Ross	EVP, GLOBAL SALES		20 Jun 2024	33,333	66,667	-		-	Employee Stock Option (right to buy)
MaxCyte Inc	Thomas M. Ross	EVP, GLOBAL SALES		20 Jun 2024	33,333	25,000	-	4.1	136,465	Common Stock
MaxCyte Inc	Thomas M. Ross	EVP, GLOBAL SALES		20 Jun 2024	33,333	58,333	-	1.6	54,699	Common Stock
Oracle Dividend	Edward Screven	Chief Corporate Architect		20 Jun 2024	33,270	2,626,764 (0%)	0%	145.1	4,827,510	Common Stock
Pure Storage Inc (Class A)	Charles H. Giancarlo	Director, CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.35 per share.	20 Jun 2024	32,815	1,201,196 (0%)	0%	68.3	2,242,905	Class A Common Stock
C4 Therapeutics Inc	Bruce L. Downey	Director		20 Jun 2024	32,500	32,500	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Owen P. Hughes	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	32,500	32,500	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Donna Roy Grogan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	32,500	32,500	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Utpal Koppikar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	32,500	32,500	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Kenneth C. Anderson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	32,500	32,500	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Laura Bessen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	32,500	32,500	-		-	Stock Option (Right to Buy)
C4 Therapeutics Inc	Malcolm Salter	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	32,500	32,500	-		-	Stock Option (Right to Buy)
Iron Mountain	John Tomovcsik	EVP, Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 88.71 per share.	20 Jun 2024	32,384	23,066 (0%)	0%	88.7	2,872,623	Common Stock, par value $.01 per share
Tectonic Therapeutic Inc	Marcella Kuhlman Ruddy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	32,065	32,065	-		-	Common Stock
Tectonic Therapeutic Inc	Peter McNamara	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	32,065	32,065	-		-	Employee Stock Option (Right to Buy)
Hagerty Inc (Class A)	Robert I. Kauffman	Director	Sale of securities on an exchange or to another person at price $ 10.40 per share.	20 Jun 2024	31,176	3,176,126	-	10.4	324,230	Class A Common Stock
Bioventus Inc (Class A)	Mark Leonard Singleton	SVP & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	31,000	94,114 (0%)	0%		0	Class A Common Stock
Bioventus Inc (Class A)	Mark Leonard Singleton	SVP & CFO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	31,000	31,000	-		-	Restricted Stock Units
Atea Pharma Inc	Bruce Polsky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	29,600	29,600	-		-	Restricted Stock Units
DocuSign Inc	Blake Jeffrey Grayson	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 51.52 per share.	20 Jun 2024	29,590	70,473 (0%)	0%	51.5	1,524,477	Common Stock
Hagerty Inc (Class A)	Robert I. Kauffman	Director	Sale of securities on an exchange or to another person at price $ 10.27 per share.	20 Jun 2024	29,240	3,207,302	-	10.3	300,295	Class A Common Stock
Asana Inc (Class A)	Tim M. Wan	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 11.44 per share.	20 Jun 2024	28,856	1,050,284	-	11.4	330,026	Class A Common Stock
Nextcure Inc	David S. Kabakoff	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	28,050	28,050	-		-	Stock Option (Right to Buy)
Tectonic Therapeutic Inc	Stefan Vitorovic	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	27,774	27,774	-		-	Common Stock
Hims & Hers Health Inc (Class A)	Andrew Dudum	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 23.37 per share.	20 Jun 2024	26,741	34,202	-	23.4	624,833	Class A Common Stock
Asana Inc (Class A)	Anne Raimondi	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 11.44 per share.	20 Jun 2024	26,588	790,894	-	11.4	304,087	Class A Common Stock
Domo Inc (Class B) Board Meeting	Joshua G. James	Director, Founder and CEO, Ten Percent Owner	Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.90 per share.	20 Jun 2024	26,126	1,105,639 (4%)	0%	6.9	180,269	Class B Common Stock
Angi Inc (Class A)	Jeremy G. Philips	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	25,799	51,600	-		-	Restricted Stock Units
Angi Inc (Class A)	Jeremy G. Philips	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	25,799	72,784 (0%)	0%		0	Class A Common Stock, par value $0.001
Angi Inc (Class A)	Suzy Welch	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	25,799	51,600	-		-	Restricted Stock Units
Angi Inc (Class A)	Suzy Welch	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	25,799	149,084 (0%)	0%		0	Class A Common Stock, par value $0.001
AMMO Inc	Robert D. Wiley	CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	25,000	295,838	-		0	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	25,000	91,250	-		-	Share Tracking Award
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Sale or transfer of securities back to the company at price $ 308.98 per share.	20 Jun 2024	25,000	36,710 (0%)	0%	309.0	7,724,500	Common Stock
United Therapeutics Corp	Paul A. Mahon	EVP & GENERAL COUNSEL	Exercise or conversion of derivative security received from the company (such as an option) at price $ 163.30 per share.	20 Jun 2024	25,000	61,710 (0%)	0%	163.3	4,082,500	Common Stock
SoundHound AI Inc (Class A)	Michael Zagorsek	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 4.04 per share.	20 Jun 2024	24,091	765,323	-	4.0	97,325	Class A Common Stock
Tectonic Therapeutic Inc	Alise S. Reicin	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,380	23,380	-		-	Employee Stock Option (Right to Buy)
Scynexis Inc	David C. Hastings	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,000	23,000	-		-	Stock Option
Scynexis Inc	David C. Hastings	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,000	46,183 (0%)	0%		0	Common Stock
Scynexis Inc	Guy Macdonald	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,000	23,000	-		-	Stock Option
Scynexis Inc	Guy Macdonald	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,000	55,000 (0%)	0%		0	Common Stock
Scynexis Inc	Steven C. Gilman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,000	47,000 (0%)	0%		0	Common Stock
Scynexis Inc	Steven C. Gilman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,000	23,000	-		-	Stock Option
Scynexis Inc	Armando Anido	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,000	23,000	-		-	Stock Option
Scynexis Inc	Armando Anido	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,000	48,000 (0%)	0%		0	Common Stock
Scynexis Inc	Ann F. Hanham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,000	46,622 (0%)	0%		0	Common Stock
Scynexis Inc	Ann F. Hanham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,000	23,000	-		-	Stock Option
Scynexis Inc	Brian Philippe Tinmouth	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,000	51,000 (0%)	0%		0	Common Stock
Scynexis Inc	Brian Philippe Tinmouth	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	23,000	23,000	-		-	Stock Option
Designer Brands Inc (Class A)	Allan J. Tanenbaum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	22,981	194,292	-		-	Stock Unit
Designer Brands Inc (Class A)	Elaine J. Eisenman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	22,981	167,534	-		-	Stock Unit
Designer Brands Inc (Class A)	Harvey L. Sonnenberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	22,981	25,180 (0%)	0%		0	Class A Common Shares
Designer Brands Inc (Class A)	Joanna T. Lau	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	22,981	97,859 (0%)	0%		0	Class A Common Shares
Designer Brands Inc (Class A)	Joseph A. Schottenstein	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	22,981	178,428 (0%)	0%		0	Class A Common Shares
Designer Brands Inc (Class A)	Joanne Zaiac	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	22,981	45,717	-		-	Stock Unit
Designer Brands Inc (Class A)	Peter S. Cobb	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	22,981	107,838	-		-	Stock Unit
Oracle Dividend	Jeffrey S. Berg	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 43.49 per share.	20 Jun 2024	22,500	233,212 (0%)	0%	43.5	978,525	Common Stock
Oracle Dividend	Jeffrey S. Berg	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	22,500	0	-		-	Stock Option
TTM Tech Inc	Douglas L. Soder	See Remarks	Sale of securities on an exchange or to another person at price $ 19.05 per share.	20 Jun 2024	22,400	214,574 (0%)	0%	19.1	426,731	Common Stock
SoundHound AI Inc (Class A)	Nitesh Sharan	Chief Financial Officer		20 Jun 2024	22,384	728,633	-	4.0	90,429	Class A Common Stock
AAON Inc	Norman H. Asbjornson	Director, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	20 Jun 2024	21,575	11,808,547 (22%)	0%		0	Common Stock, par value $.004
Mistras Grp Inc	Richard H. Glanton	Director	Sale of securities on an exchange or to another person at price $ 7.68 per share.	20 Jun 2024	21,000	42,117 (0%)	0%	7.7	161,280	Common Stock
EverCommerce Inc	Richard A. Simonson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,366	56,523	-		0	Common Stock
EverCommerce Inc	Penny Baldwin-Leonard	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,366	56,523	-		0	Common Stock
EverCommerce Inc	Debby Soo	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,366	35,935	-		0	Common Stock
Pure Storage Inc (Class A)	Ajay Singh	Chief Product Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.35 per share.	20 Jun 2024	20,361	322,473 (0%)	0%	68.3	1,391,674	Class A Common Stock
Liquidia Corp	Arthur S. Kirsch	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,359	22,359 (0%)	0%		0	Common Stock
Liquidia Corp	Stephen Bloch	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,359	20,359 (0%)	0%		0	Common Stock
Liquidia Corp	Paul B. Manning	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,359	299,689 (1%)	0%		0	Common Stock
Liquidia Corp	Joanna Horobin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,359	20,359 (0%)	0%		0	Common Stock
Liquidia Corp	Ramandeep Singh	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,359	20,359 (0%)	0%		0	Common Stock
Liquidia Corp	Katherine Rielly-Gauvin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,359	20,359 (0%)	0%		0	Common Stock
Liquidia Corp	Damian deGoa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,359	68,075 (0%)	0%		0	Common Stock
Acrivon Therapeutics Inc	Michael J. Tomsicek	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,275	20,275	-		-	Stock Option (Right to Buy)
Acrivon Therapeutics Inc	Charles M. Baum	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,275	20,275	-		-	Stock Option (Right to Buy)
Acrivon Therapeutics Inc	Sharon Shacham	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,275	20,275	-		-	Stock Option (Right to Buy)
Acrivon Therapeutics Inc	Derek DiRocco	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,275	20,275	-		-	Stock Option (Right to Buy)
Nurix Therapeutics Inc	Hans van Houte	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 20.01 per share.	20 Jun 2024	20,000	48,333	-	20.0	400,216	Common Stock
Niagen Bioscience Inc	Frank L. Jaksch	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,000	20,000	-		-	Stock Option (right to buy)
Niagen Bioscience Inc	Ann Cohen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,000	20,000	-		-	Stock Option (right to buy)
Niagen Bioscience Inc	Steven D. Rubin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,000	20,000	-		-	Stock Option (right to buy)
Niagen Bioscience Inc	Hamed Shahbazi	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,000	20,000	-		-	Stock Option (right to buy)
Niagen Bioscience Inc	Wendy Yu	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,000	20,000	-		-	Stock Option (right to buy)
Niagen Bioscience Inc	Kristin Patrick	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,000	20,000	-		-	Stock Option (right to buy)
Niagen Bioscience Inc	Gary Ng	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,000	20,000	-		-	Stock Option (right to buy)
Vivos Therapeutics Inc	R. Kirk Huntsman	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	20,000	49,334	-		-	Stock Option (Right to Buy)
Bioventus Inc (Class A)	Anthony D’Adamio	SVP & General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	19,850	19,850	-		-	Restricted Stock Units
Bioventus Inc (Class A)	Anthony D’Adamio	SVP & General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	19,850	101,480 (0%)	0%		0	Class A Common Stock
Purple Innovation Inc	George Turner Ulrich	Principal Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	19,728	19,728	-		-	Restricted Stock Units
DocuSign Inc	Blake Jeffrey Grayson	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 50.60 per share.	20 Jun 2024	19,533	100,063 (0%)	0%	50.6	988,370	Common Stock
Atlas Energy Soln Inc (Class A)	Gregory M. Shepard	Member of 10% Owner Group	Purchase of securities on an exchange or from another person at price $ 19.25 per share.	20 Jun 2024	19,132	7,402,150	-	19.3	368,291	Common Stock
Yext Inc	Darryl Bond	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.99 per share.	20 Jun 2024	19,041	331,083 (0%)	0%	5.0	95,015	Common Stock
Tectonic Therapeutic Inc	Christian Cortis	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	18,704	18,704	-		-	Employee Stock Option (Right to Buy)
Tectonic Therapeutic Inc	Marcella Kuhlman Ruddy	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	18,704	18,704	-		-	Employee Stock Option (Right to Buy)
Tectonic Therapeutic Inc	Peter McNamara	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	18,704	18,704	-		-	Employee Stock Option (Right to Buy)
Nextcure Inc	Stephen W. Webster	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	18,700	18,700	-		-	Stock Option (Right to Buy)
Nextcure Inc	John G. Houston	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	18,700	18,700	-		-	Stock Option (Right to Buy)
Nextcure Inc	Ellen G. Feigal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	18,700	18,700	-		-	Stock Option (Right to Buy)
Nextcure Inc	Anne Borgman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	18,700	18,700	-		-	Stock Option (Right to Buy)
Lindblad Expeditions Holdings Inc	Alex Schultz	Director	Purchase of securities on an exchange or from another person at price $ 7.69 per share.	20 Jun 2024	18,517	194,715 (0%)	0%	7.7	142,396	Common Stock
Hims & Hers Health Inc (Class A)	Andrew Dudum	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 22.35 per share.	20 Jun 2024	18,314	60,943	-	22.3	409,239	Class A Common Stock
Galecto Inc	David Shapiro	Director		20 Jun 2024	18,000	18,000	-		-	Stock Option (right to buy)
Galecto Inc	Anne Prener	Director		20 Jun 2024	18,000	18,000	-		-	Stock Option (right to buy)
Galecto Inc	Amit D. Munshi	Director		20 Jun 2024	18,000	18,000	-		-	Stock Option (right to buy)
Galecto Inc	Jayson Dallas	Director		20 Jun 2024	18,000	18,000	-		-	Stock Option (right to buy)
Vicor Corp	Michael McNamara	Director, General Manager Mfg. Ops	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.77 per share.	20 Jun 2024	17,724	17,969 (0%)	0%	6.8	119,991	Common Stock
Vicor Corp	Michael McNamara	Director, General Manager Mfg. Ops	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	17,724	0	-		-	Non Qualified Stock Option
Atea Pharma Inc	Bruce Polsky	Director	Sale of securities on an exchange or to another person at price $ 3.49 per share.	20 Jun 2024	17,544	65,606	-	3.5	61,144	Common Stock
Orchestra BioMed Holdings Inc	Eric A. Rose	Director		20 Jun 2024	17,068	17,068	-		-	Stock Option (Right to Buy)
Orchestra BioMed Holdings Inc	Eric S. Fain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	17,068	17,068	-		-	Stock Option (Right to Buy)
Orchestra BioMed Holdings Inc	Jason M. Aryeh	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	17,068	17,068	-		-	Stock Option (Right to Buy)
Orchestra BioMed Holdings Inc	David C. Pacitti	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	17,068	17,068	-		-	Stock Option (Right to Buy)
Orchestra BioMed Holdings Inc	Pamela Yanchik Connealy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	17,068	17,068	-		-	Stock Option (Right to Buy)
UiPath Inc (Class A)	Karenann K. Terrell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	17,021	65,053	-		0	Class A Common Stock
UiPath Inc (Class A)	Daniel D. Springer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	17,021	119,055	-		0	Class A Common Stock
UiPath Inc (Class A)	Richard P. Wong	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	17,021	54,424	-		0	Class A Common Stock
UiPath Inc (Class A)	Laela Sturdy	Director		20 Jun 2024	17,021	54,424	-		0	Class A Common Stock
UiPath Inc (Class A)	Michael Gordon	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	17,021	159,400	-		0	Class A Common Stock
UiPath Inc (Class A)	Philippe Botteri	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	17,021	3,143,587	-		0	Class A Common Stock
UiPath Inc (Class A)	June Yang	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	17,021	43,107	-		0	Class A Common Stock
SoundHound AI Inc (Class A)	James Hom	Director, Chief Product Officer	Sale of securities on an exchange or to another person at price $ 4.04 per share.	20 Jun 2024	16,716	486,989	-	4.0	67,531	Class A Common Stock
SoundHound AI Inc (Class A)	Majid Emami	VP, Engineering, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 4.04 per share.	20 Jun 2024	16,716	450,776	-	4.0	67,531	Class A Common Stock
Revolution Medicines Inc	Alexis A. Borisy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	16,700	16,700	-		-	Stock Option (Right to Buy)
Revolution Medicines Inc	Sandra J. Horning	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	16,700	16,700	-		-	Stock Option (Right to Buy)
Revolution Medicines Inc	Lorence H. Kim	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	16,700	16,700	-		-	Stock Option (Right to Buy)
Revolution Medicines Inc	Elizabeth McKee Anderson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	16,700	16,700	-		-	Stock Option (Right to Buy)
Revolution Medicines Inc	Barbara L. Weber	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	16,700	16,700	-		-	Stock Option (Right to Buy)
Revolution Medicines Inc	Sushil Patel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	16,700	16,700	-		-	Stock Option (Right to Buy)
Revolution Medicines Inc	Flavia Borellini	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	16,700	16,700	-		-	Stock Option (Right to Buy)
AMMO Inc	Jared R. Smith	Director, CEO		20 Jun 2024	16,159	351,778	-	1.9	30,217	Common Stock
SoundHound AI Inc (Class A)	Timothy Stonehocker	Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 4.04 per share.	20 Jun 2024	16,039	867,531	-	4.0	64,796	Class A Common Stock
GigaCloud Tech Inc (Class A) Board Meeting	Frank Hurst Lin	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 30.14 per share.	20 Jun 2024	15,993	4,588,873	-	30.1	482,055	Class A Ordinary Shares, par value $0.05 per share
Revolution Medicines Inc	Alexis A. Borisy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	15,955	15,955	-		-	Stock Option (Right to Buy)
Revolution Medicines Inc	Lorence H. Kim	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	15,955	15,955	-		-	Stock Option (Right to Buy)
Revolution Medicines Inc	Elizabeth McKee Anderson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	15,955	15,955	-		-	Stock Option (Right to Buy)
Revolution Medicines Inc	Barbara L. Weber	Director		20 Jun 2024	15,955	15,955	-		-	Stock Option (Right to Buy)
Revolution Medicines Inc	Sushil Patel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	15,955	15,955	-		-	Stock Option (Right to Buy)
Revolution Medicines Inc	Flavia Borellini	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	15,955	15,955	-		-	Stock Option (Right to Buy)
Lindblad Expeditions Holdings Inc	Alex Schultz	Director	Purchase of securities on an exchange or from another person at price $ 7.48 per share.	20 Jun 2024	15,953	176,198 (0%)	0%	7.5	119,328	Common Stock
TeraWulf Inc Fundraise	Kenneth J. Deane	Chief Acct Officer + Treasurer		20 Jun 2024	15,525	375,720	-		-	Common stock, $0.001 par value per share
Alphabet (Class A)	Sundar Pichai	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 177.23 per share.	20 Jun 2024	15,096	2,220,415 (0%)	0%	177.2	2,675,393	Class C Capital Stock
Cloudflare Inc (Class A) Analyst Upgrade	Thomas Josef Seifert	CHIEF FINANCIAL OFFICER		20 Jun 2024	15,000	324,937 (0%)	0%		-	Class A Common Stock
Cloudflare Inc (Class A) Analyst Upgrade	Thomas Josef Seifert	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	15,000	495,341	-		-	Employee Stock Option (right to buy)
Cloudflare Inc (Class A) Analyst Upgrade	Thomas Josef Seifert	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	15,000	23,925	-		-	Class B Common Stock
Cloudflare Inc (Class A) Analyst Upgrade	Thomas Josef Seifert	CHIEF FINANCIAL OFFICER		20 Jun 2024	15,000	8,925	-		-	Class B Common Stock
Sonoma Pharma Inc	Poggetto John Dal	Controller	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	15,000	15,000 (0%)	0%		-	Common Stock, $0.0001 par value
Vivos Therapeutics Inc	Bradford K. Amman	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	15,000	31,667	-		-	Stock Option (Right to Buy)
Aura Biosciences Inc	Sapna Srivastava	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	14,500	14,500	-		-	Stock Option (Right to Buy)
Aura Biosciences Inc	Antony C. Mattessich	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	14,500	14,500	-		-	Stock Option (Right to Buy)
Oracle Dividend	Jeffrey S. Berg	Director	Sale of securities on an exchange or to another person at price $ 143.36 per share.	20 Jun 2024	14,325	210,712 (0%)	0%	143.4	2,053,699	Common Stock
Yext Inc	Ho Shin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	14,063	169,532 (0%)	0%		-	Common Stock
Yext Inc	Ho Shin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	14,063	112,500	-		-	Restricted Stock Unit
Scilex Holding Co	Jaisim Shah	Director, See Remarks		20 Jun 2024	14,000	47,333	-	1.7	24,220	Common Stock
Scilex Holding Co	Jaisim Shah	Director, See Remarks		20 Jun 2024	14,000	7,880,598	-		-	Nonstatutory Stock Option (right to buy)
Hagerty Inc (Class A)	Robert I. Kauffman	Director	Sale of securities on an exchange or to another person at price $ 10.57 per share.	20 Jun 2024	13,726	3,162,400	-	10.6	145,084	Class A Common Stock
Box Inc (Class A)	Dylan C. Smith	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.58 per share.	20 Jun 2024	13,251	1,539,661 (1%)	0%	25.6	338,961	Class A Common Stock
PepGen Inc	Laurie B. Keating	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	13,000	13,000	-		-	Stock Option (Right to Buy)
PepGen Inc	Heidi Henson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	13,000	13,000	-		-	Stock Option (Right to Buy)
PepGen Inc	Joshua Resnick	Director		20 Jun 2024	13,000	13,000	-		-	Stock Option (Right to Buy)
PepGen Inc	Habib Joseph Dable	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	13,000	13,000	-		-	Stock Option (Right to Buy)
PepGen Inc	Christopher Ashton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	13,000	13,000	-		-	Stock Option (Right to Buy)
Pure Storage Inc (Class A)	Kevan Krysler	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.35 per share.	20 Jun 2024	12,678	532,919 (0%)	0%	68.3	866,541	Class A Common Stock
Pure Storage Inc (Class A)	Dan FitzSimons	Chief Revenue Officer		20 Jun 2024	12,623	125,482 (0%)	0%	68.3	862,782	Class A Common Stock
Lovesac Co	Shawn Nelson	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 23.35 per share.	20 Jun 2024	12,000	172,843 (1%)	0%	23.3	280,153	Common Stock, $0.00001 par value
Agios Pharma Inc	Jeffrey D. Capello	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,774	11,774	-		-	Stock options (right to buy)
Agios Pharma Inc	Kaye Foster	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,774	11,774	-		-	Stock options (right to buy)
Agios Pharma Inc	Jacqualyn A. Fouse	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,774	11,774	-		-	Stock options (right to buy)
Agios Pharma Inc	Cynthia Smith	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,774	11,774	-		-	Stock options (right to buy)
Agios Pharma Inc	David P. Schenkein	Director		20 Jun 2024	11,774	11,774	-		-	Stock options (right to buy)
Agios Pharma Inc	Maykin Ho	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,774	11,774	-		-	Stock options (right to buy)
Agios Pharma Inc	David T. Scadden	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,774	11,774	-		-	Stock options (right to buy)
Agios Pharma Inc	Rahul D. Ballal	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,774	11,774	-		-	Stock options (right to buy)
Tectonic Therapeutic Inc	Phillip B. Donenberg	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,760	11,760	-		-	Stock Option (Right to Buy)
Tectonic Therapeutic Inc	Timothy A. Springer	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,760	11,760	-		-	Stock Option (Right to Buy)
Tectonic Therapeutic Inc	Stefan Vitorovic	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,760	11,760	-		-	Stock Option (Right to Buy)
Lifetime Brands Inc	Cherrie Nanninga	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,653	100,837 (0%)	0%		0	Common Stock
Lifetime Brands Inc	Craig Phillips	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,653	617,516 (2%)	0%		0	Common Stock
Lifetime Brands Inc	Jeffrey Siegel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,653	1,160,251 (5%)	0%		0	Common Stock
Lifetime Brands Inc	Michael J. Regan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,653	85,611 (0%)	0%		0	Common Stock
Lifetime Brands Inc	Veronique Gabai-Pinsky	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,653	51,877 (0%)	0%		0	Common Stock
Lifetime Brands Inc	Michael Schnabel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,653	66,563 (0%)	0%		0	Common Stock
Lifetime Brands Inc	Bruce G. Pollack	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,653	66,563 (0%)	0%		0	Common Stock
Lifetime Brands Inc	Rachael A. Jarosh	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	11,653	56,074 (0%)	0%		0	Common Stock
Alset Inc	Fai Heng Chan	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 1.15 per share.	20 Jun 2024	11,556	5,673,095	-	1.1	13,289	Common Stock
Pure Storage Inc (Class A)	John Colgrove	Director, Chief Visionary Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.35 per share.	20 Jun 2024	11,486	7,328,207 (2%)	0%	68.3	785,068	Class A Common Stock
Roivant Sciences Ltd	Eric Venker	President & COO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.80 per share.	20 Jun 2024	10,945	457,252	-	10.8	118,206	Common Shares
Roivant Sciences Ltd	Matthew Gline	Director, CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.80 per share.	20 Jun 2024	10,945	1,131,816	-	10.8	118,206	Common Shares
Tectonic Therapeutic Inc	Peter McNamara	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	10,688	10,688	-		-	Common Stock
ChargePoint Holdings Inc (Class A)	Henrik Gerdes	Chief Accounting Officer	Sale of securities on an exchange or to another person at price $ 1.40 per share.	20 Jun 2024	10,629	427,375	-	1.4	14,850	Common Stock
Aura Biosciences Inc	Sapna Srivastava	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	10,500	10,500	-		0	Common Stock
Aura Biosciences Inc	Antony C. Mattessich	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	10,500	10,500	-		0	Common Stock
Exlservice Hldgs Inc	Vikram S. Pandit	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	10,344	65,939	-		-	Restricted Stock Units
Revolution Medicines Inc	Sandra J. Horning	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	10,248	10,248	-		-	Stock Option (Right to Buy)
Medifast Inc	Ming Xian	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	10,149	14,961	-		-	Restricted Stock Units (cash settled)
Ooma Inc	James A. Gustke	SVP of Marketing	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	10,013	34,987	-		-	Employee Stock Option (right to buy)
Ooma Inc	James A. Gustke	SVP of Marketing	Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.04 per share.	20 Jun 2024	10,013	193,611 (0%)	0%	6.0	60,479	Common Stock
Sezzle Inc	Paul M. Purcell	Former Director	Sale of securities on an exchange or to another person at price $ 85.16 per share.	20 Jun 2024	10,000	449,687	-	85.2	851,579	Common Stock
Lument Finance Trust Inc	William A. Houlihan	Director	Grant, award, or other acquisition of securities at price $ 2.50 per share.	20 Jun 2024	10,000	202,732 (0%)	0%	2.5	25,000	common stock
AMMO Inc	Randy Luth	Director		20 Jun 2024	10,000	513,555	-		0	Common Stock
AMMO Inc	Russell William Wallace	Director		20 Jun 2024	10,000	560,000	-		0	Common Stock
AMMO Inc	Jessica M. Lockett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	10,000	130,000	-		0	Common Stock
AMMO Inc	Richard R. Childress	Director		20 Jun 2024	10,000	287,500	-		0	Common Stock
AMMO Inc	Steve F. Urvan	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	10,000	20,110,000	-		0	Common Stock
AMMO Inc	Christos Tsentas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	10,000	56,413	-		0	Common Stock
Unifirst Corp	Levenstein Cecelia	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 153.29 per share.	20 Jun 2024	9,733	58,325 (0%)	0%	153.3	1,491,972	Common Stock
Cloudflare Inc (Class A) Analyst Upgrade	Thomas Josef Seifert	CHIEF FINANCIAL OFFICER	Sale of securities on an exchange or to another person at price $ 78.05 per share.	20 Jun 2024	9,643	315,294 (0%)	0%	78.0	752,589	Class A Common Stock
Netsol Tech Inc	Michael Richard Francis	Director		20 Jun 2024	9,559	0 (0%)	0%	2.5	24,184	Common Stock
Yext Inc	Ho Shin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	9,375	9,375	-		-	Restricted Stock Unit
Yext Inc	Ho Shin	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	9,375	152,344 (0%)	0%		-	Common Stock
Yext Inc	Ho Shin	General Counsel	Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.99 per share.	20 Jun 2024	9,325	160,207 (0%)	0%	5.0	46,532	Common Stock
Maplebear Inc	Morgan Fong	GENERAL COUNSEL & SECRETARY	Sale of securities on an exchange or to another person at price $ 33.86 per share.	20 Jun 2024	9,228	381,841	-	33.9	312,448	Common Stock
Mastercard	Craig E. Vosburg	Chief Services Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 112.31 per share.	20 Jun 2024	9,028	67,967 (0%)	0%	112.3	1,013,935	Class A Common Stock
Mastercard	Craig E. Vosburg	Chief Services Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	9,028	0	-		-	Employee Stock Option (right to buy)
Mastercard	Craig E. Vosburg	Chief Services Officer	Sale of securities on an exchange or to another person at price $ 451.06 per share.	20 Jun 2024	9,028	58,939 (0%)	0%	451.1	4,072,170	Class A Common Stock
Asana Inc (Class A)	Eleanor Lacey	GC, Corporate Secretary	Sale of securities on an exchange or to another person at price $ 11.44 per share.	20 Jun 2024	9,000	389,149	-	11.4	102,933	Class A Common Stock
Middlesex Water Co.	A. Bruce O'Connor	SVP, CFO and Treasurer	Other type of transaction at price $ 51.64 per share.	20 Jun 2024	8,911	0	-	51.6	460,164	Common Stock (Restricted Stock Book Entry)
PepGen Inc	Howard Mayer	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	8,667	8,667	-		-	Stock Option (Right to Buy)
Bioventus Inc (Class A)	Katrina Church	SVP & Chief Compliance Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	8,600	8,600	-		-	Restricted Stock Units
Bioventus Inc (Class A)	Katrina Church	SVP & Chief Compliance Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	8,600	43,758 (0%)	0%		0	Class A Common Stock
Netsol Tech Inc	Michael Richard Francis	Director		20 Jun 2024	8,569	9,559 (0%)	0%	2.6	22,194	Common Stock
Oracle Dividend	Jeffrey S. Berg	Director	Sale of securities on an exchange or to another person at price $ 142.68 per share.	20 Jun 2024	8,175	225,037 (0%)	0%	142.7	1,166,416	Common Stock
Tectonic Therapeutic Inc	Marc Schwabish	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	8,016	8,016	-		-	Employee Stock Option (Right to Buy)
eBay	Paul S. Pressler	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	7,937	85,972 (0%)	0%		0	Common Stock
eBay	Paul S. Pressler	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	7,937	0	-		-	Restricted Stock Units -4
Resideo Tech Inc	John S. Stroup	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	7,825	7,825 (0%)	0%		0	Common Stock
Resideo Tech Inc	Nathan K. Sleeper	Director		20 Jun 2024	7,825	7,825 (0%)	0%		0	Common Stock
Courtside Grp Inc	D. Jonathan Merriman	Director	Purchase of securities on an exchange or from another person at price $ 1.65 per share.	20 Jun 2024	7,700	96,539	-	1.7	12,705	Common Stock, $0.00001 par value
Enovix Corp	Gregory Reichow	Director	Sale of securities on an exchange or to another person at price $ 12.14 per share.	20 Jun 2024	7,500	8,129	-	12.1	91,050	Common Stock
Hims & Hers Health Inc (Class A)	Michael Chi	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.90 per share.	20 Jun 2024	7,500	192,826	-	13.9	104,250	Class A Common Stock
Hims & Hers Health Inc (Class A)	Michael Chi	Chief Commercial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	7,500	96,582	-		-	Stock Option (right to buy)
Hims & Hers Health Inc (Class A)	Michael Chi	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 24.50 per share.	20 Jun 2024	7,500	185,326	-	24.5	183,750	Class A Common Stock
Alphabet (Class A)	Sundar Pichai	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 177.75 per share.	20 Jun 2024	7,404	2,213,011 (0%)	0%	177.8	1,316,085	Class C Capital Stock
Exlservice Hldgs Inc	Jaynie Miller Studenmund	Director		20 Jun 2024	7,060	54,260	-		-	Restricted Stock Units
Exlservice Hldgs Inc	Thomas A. Bartlett	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	7,060	9,033	-		-	Restricted Stock Units
Exlservice Hldgs Inc	Nitin Sahney	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	7,060	81,575	-		-	Restricted Stock Units
Exlservice Hldgs Inc	Andreas Fibig	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	7,060	15,575	-		-	Restricted Stock Units
Exlservice Hldgs Inc	Sarah K. Williamson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	7,060	13,110	-		-	Restricted Stock Units
Exlservice Hldgs Inc	Kristy M. Pipes	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	7,060	30,510	-		-	Restricted Stock Units
Exponent Inc	Paul R. Johnston	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	7,000	0	-		-	Non-Qualified Stock Option (right to buy)
Exponent Inc	Paul R. Johnston	Director	Sale of securities on an exchange or to another person at price $ 95.34 per share.	20 Jun 2024	7,000	80,742 (0%)	0%	95.3	667,358	Common Stock
Exponent Inc	Paul R. Johnston	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 29.05 per share.	20 Jun 2024	7,000	87,742 (0%)	0%	29.1	203,350	Common Stock
CRISPR Therapeutics AG	Julianne Bruno	Chief Operating Officer		20 Jun 2024	7,000	10,111 (0%)	0%		-	Common Shares
CRISPR Therapeutics AG	Julianne Bruno	Chief Operating Officer		20 Jun 2024	7,000	0	-		-	Restricted Stock Units
AMMO Inc	Robert D. Wiley	CFO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.87 per share.	20 Jun 2024	6,999	288,839	-	1.9	13,088	Common Stock
Lovesac Co	Shawn Nelson	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 23.31 per share.	20 Jun 2024	6,988	165,855 (1%)	0%	23.3	162,925	Common Stock, $0.00001 par value
Signet Jewelers Ltd	Joan M. Hilson	* See Remarks	Sale of securities on an exchange or to another person at price $ 91.71 per share.	20 Jun 2024	6,805	190,426 (0%)	0%	91.7	624,089	Common Shares, par value $0.18
Vericel Corp	Sean C. Flynn	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	6,772	116,474	-		-	Stock Option (Right to Buy)
Vericel Corp	Sean C. Flynn	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 45.02 per share.	20 Jun 2024	6,772	487 (0%)	0%	45.0	304,875	Common Stock
Vericel Corp	Sean C. Flynn	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.25 per share.	20 Jun 2024	6,772	7,259 (0%)	0%	16.3	110,045	Common Stock
Vericel Corp	Sean C. Flynn	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.25 per share.	20 Jun 2024	6,754	7,241 (0%)	0%	16.3	109,753	Common Stock
Vericel Corp	Sean C. Flynn	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	6,754	123,246	-		-	Stock Option (Right to Buy)
Vericel Corp	Sean C. Flynn	Chief Legal Officer	Sale of securities on an exchange or to another person at price $ 45.04 per share.	20 Jun 2024	6,754	487 (0%)	0%	45.0	304,200	Common Stock
Boundless Bio Inc	Jonathan E. Lim	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	6,610	6,610	-		-	Stock Option (Right to Buy)
Medifast Inc	Jeffrey J. Brown	Director		20 Jun 2024	6,596	12,379 (0%)	0%		0	Common Stock
Medifast Inc	Scott Schlackman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	6,596	14,380 (0%)	0%		0	Common Stock
Medifast Inc	Michael A. Hoer	Director		20 Jun 2024	6,596	14,971 (0%)	0%		0	Common Stock
Medifast Inc	Andrea B. Thomas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	6,596	12,849 (0%)	0%		0	Common Stock
Medifast Inc	Elizabeth A. Geary	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	6,596	8,377 (0%)	0%		0	Common Stock
ZipRecruiter Inc (Class A)	Timothy Yarbrough	EVP & CHIEF FINANCIAL OFFICER	Sale of securities on an exchange or to another person at price $ 8.51 per share.	20 Jun 2024	6,552	168,168	-	8.5	55,770	Class A Common Stock
eBay	Paul S. Pressler	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	6,501	6,501	-		-	Restricted Stock Units -5
Delta Air Lines Estimates Beat Results Board Meeting	David S. Taylor	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	6,460	105,940 (0%)	0%		-	Common Stock
Life360 Inc	Russell Burke	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.25 per share.	20 Jun 2024	6,213	135,108	-	31.2	194,156	Common stock
Blend Labs Inc (Class A)	Oxana Tkach	PRINCIPAL ACCOUNTING OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	6,142	95,988	-		-	Class A Common Stock
Blend Labs Inc (Class A)	Oxana Tkach	PRINCIPAL ACCOUNTING OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	6,142	6,143	-		-	Restricted Stock Units
Vicor Corp	Michael McNamara	Director, General Manager Mfg. Ops	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	6,081	6,081	-		-	Non Qualified Stock Option
Ncino Inc	Steven A. Collins	Director		20 Jun 2024	5,874	66,790	-		0	Common Stock
Ncino Inc	Jonathan J. Doyle	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	5,874	69,540	-		0	Common Stock
Ncino Inc	Pam Kilday	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	5,874	26,804	-		0	Common Stock
Ncino Inc	Spencer Lake	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	5,874	13,665	-		0	Common Stock
Ncino Inc	William Spruill	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	20 Jun 2024	5,874	21,991	-		0	Common Stock
GeneDx Holdings Corp (Class A)	Joshua Ruch	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	5,828	7,853	-		0	Class A Common Stock
GeneDx Holdings Corp (Class A)	Joshua Ruch	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	5,828	0	-		-	Restricted Stock Unit
GeneDx Holdings Corp (Class A)	Keith A. Meister	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	5,828	7,205	-		0	Class A Common Stock
GeneDx Holdings Corp (Class A)	Keith A. Meister	Director, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2024	5,828	0	-		-	Restricted Stock Unit

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Jun 20, 2024

Monitor US insider transactions and discover insider buying and selling of stocks on Jun 20, 2024.

The latest disclosure under SEC insider trading regulations was reported by Tectonic Therapeutic Inc.., where the revocation of 2,692,005 Common Stock of common stock was executed . This transaction was reported to the Securities and Exchange Commission on June 20, 2024.

Screeners based on Insider Trading parameters